Single-cell Transcriptomic Analysis of Eutopic Endometrium and Ectopic Lesions of Adenomyosis

In: Research Square · 2020 · doi:10.21203/rs.3.rs-127243/v1 · W4243881766
preprint OA: green CC0 ⤵ 1 in-corpus citation
📄 Open PDF View on OpenAlex View at publisher
AI-generated summary by claude@2026-06+body, 2026-06-07

Single-cell RNA sequencing of adenomyosis samples revealed increased cancer-, inflammation-, and motility-associated terms, suggesting epithelial-endothelial transition and vasculogenic mimicry formation contribute to the disease's progression.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07

This paper used single-cell RNA sequencing to compare control endometrium from hysteromyoma patients with eutopic endometrium and ectopic adenomyosis lesions from one adenomyosis patient, followed by validation in additional leiomyoma (n=3) and adenomyosis (n=3) samples using immunofluorescence and CD34-PAS double staining to assess vasculogenic mimicry. The authors report that ectopic lesions show increased epithelial–endothelial marker colocalization (EPCAM with PECAM1), presence of a cell subpopulation with high copy number variation and tumour-like features, and an epithelial-to-endothelial transition associated with PAS-positive/CD34-negative vasculogenic mimicry formations. They also identify VNN1- and EPCAM-positive epithelial subclusters with active cell motility, and describe enrichment of cancer-, cell motility- and inflammation-related processes, alongside proliferation and angiogenesis, in adenomyosis progression, while noting the limited scRNA-seq sampling (n=1 per key group). This paper is centrally about endometriosis and/or adenomyosis—adenomyosis—using single-cell profiling of eutopic endometrium versus ectopic adenomyosis lesions and validation of epithelial–endothelial transition and vasculogenic mimicry.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

adenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (39)

Cited by (1)

Source provenance

europepmc
last seen: 2026-06-15T06:13:43.845377+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK